Assignee
MOLECULAR TECH LABORATORIES LLC
US·2 granted patents·3 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
5 records- 0167US2025099550A1Methods for treating alzheimers disease and related dementias and aging using pegylated growth hormone receptor antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2024·Application pending·0 cites
- 0265US2024082362A1Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2023·Application pending·0 cites
- 0364US2025101076A1Growth hormone receptor antagonists exhibiting increased receptor binding properties and increased serum half-lifeMOLECULAR TECH LABORATORIES LLC·Filed 2024·Application pending·0 cites
- 0460US11857602B2Growth hormone antagonist and anti-cancer composition combination therapyMOLECULAR TECH LABORATORIES LLC·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 0547US11452763B2Therapeutic pegylated growth hormone antagonistsMOLECULAR TECH LABORATORIES LLC·Filed 2020·Granted Sep 27, 2022·0 cites·7 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →